News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Company Profile for Nuvera Biosciences



4/3/2009 11:49:54 AM

(BUSINESS WIRE)-- Nuvera Biosciences is developing molecular diagnostic tests that will help significantly improve treatment selection and quality of patient management in cancer. The Company has developed of four gene-based breast cancer tests for determining individual patient response to standard-of-care therapy. The tests have been clinically validated with trials at MD Anderson Cancer Center, a founding partner and other leading cancer centers worldwide.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES